Guiding the Treatment of Anterior Eye Disease with Optical Coherence Tomography

光学相干断层扫描指导眼前部疾病的治疗

基本信息

  • 批准号:
    8324529
  • 负责人:
  • 金额:
    $ 75.19万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-03-01 至 2016-08-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY Optical coherence tomography (OCT) is a cross-sectional and 3-dimensional (3-D) imaging technology with very fine spatial resolution (5 ¿m). This project develops the methods and software needed for high-precision OCT measurements of the eye to guide implant, laser, and transplant surgeries in the front part of the eye. In the proposed continuation of the project, a new generation of OCT that has very high speed (about 10 times faster than before, taking an image in as little as 2/1000 of a second) and extended range will enable new types of measurements to be done accurately. The Specific Aims are as follows: (1) To develop ultrahigh-speed OCT hardware and software for measuring optical surfaces of the anterior eye. Intrinsic eye movements effectively limit measurement of corneal shape by commercial OCT. This will be overcome by several approaches, including ultrahigh-speed OCT at 500 kHz, dual-beam OCT to simultaneously capture the shape of both the cornea and lens, simultaneous capture of Placido-ring videokeratography, and motion correction software. The goal is to provide reliable measurements on front and back surfaces of both the cornea and crystalline lens. (2) To develop an OCT-based intraocular lens power formula. Currently, surgeons lack an accurate way to calculate precise intraocular lens (IOL) power for cataract patients who previously had laser vision correction. These patients may be left near- or far-sighted after cataract surgery. An OCT-based IOL formula, using measurements of both anterior and posterior corneal powers, can give surgeons more precise information that will significantly improve visual outcomes. The OCT-based IOL formula will be tested in a clinical trial. (3) To develop OCT-guided excimer laser surface ablation. The excimer laser can remove cloudy layers from the front of the cornea and correct distorted shape due to keratoconus or transplant surgery. We have developed 3-D OCT-based planning to optimally remove cloudiness due to corneal scars and stromal dystrophies. This method will be tested in a larger clinical trial. We will improve the method by adding 3-D OCT measurement of corneal shape (topography) to plan the correction of any shape distortion. (4) To develop OCT-guided laser-assisted anterior and posterior lamellar keratoplasty. Most corneal diseases involve only the inner or outer layer of the cornea. Thus a partial thickness transplant can treat these diseases while avoiding the complications of full-thickness transplantations (rejection, irregular wound shape, etc). However, manual dissection of corneal layers is technically difficult and vision after surgery is limited by the rough interfaces. We have developed OCT methods to guide the shaping and smoothing of donor and host corneas with a combination of excimer laser to create smooth interfaces and femtosecond laser to create tongue-in-groove edge fits. Pilot clinical trials of these techniques are proposed. The goal is to develop surgeries that reliably improve the vision in patients with keratoconus, corneal dystrophies, and deep scars.

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

David Huang其他文献

David Huang的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('David Huang', 18)}}的其他基金

Advanced transepithelial corneal collagen crosslinking
先进的跨上皮角膜胶原交联
  • 批准号:
    10741684
  • 财政年份:
    2023
  • 资助金额:
    $ 75.19万
  • 项目类别:
Applications of ultrahigh-speed long-range wide-field OCT in anterior eye diseases
超高速远距离宽视场OCT在眼前部疾病中的应用
  • 批准号:
    10335273
  • 财政年份:
    2018
  • 资助金额:
    $ 75.19万
  • 项目类别:
Functional and Structural Optical Coherence Tomography for Glaucoma
青光眼的功能性和结构性光学相干断层扫描
  • 批准号:
    8479117
  • 财政年份:
    2013
  • 资助金额:
    $ 75.19万
  • 项目类别:
Functional and Structural Optical Coherence Tomography for Glaucoma
青光眼的功能性和结构性光学相干断层扫描
  • 批准号:
    8916743
  • 财政年份:
    2013
  • 资助金额:
    $ 75.19万
  • 项目类别:
Functional and Structural Optical Coherence Tomography for Glaucoma
青光眼的功能性和结构性光学相干断层扫描
  • 批准号:
    10211838
  • 财政年份:
    2013
  • 资助金额:
    $ 75.19万
  • 项目类别:
Functional and Structural Optical Coherence Tomography for Glaucoma
青光眼的功能性和结构性光学相干断层扫描
  • 批准号:
    8740482
  • 财政年份:
    2013
  • 资助金额:
    $ 75.19万
  • 项目类别:
Functional and Structural Optical Coherence Tomography for Glaucoma
青光眼的功能性和结构性光学相干断层扫描
  • 批准号:
    10430080
  • 财政年份:
    2013
  • 资助金额:
    $ 75.19万
  • 项目类别:
Functional and Structural Optical Coherence Tomography for Glaucoma
青光眼的功能性和结构性光学相干断层扫描
  • 批准号:
    9130226
  • 财政年份:
    2013
  • 资助金额:
    $ 75.19万
  • 项目类别:
Guiding the Treatment of Anterior Eye Disease with Optical Coherence Tomography
光学相干断层扫描指导眼前部疾病的治疗
  • 批准号:
    8531251
  • 财政年份:
    2008
  • 资助金额:
    $ 75.19万
  • 项目类别:
Guiding the Treatment of Anterior Eye Disease with Optical Coherence Tomography
光学相干断层扫描指导眼前部疾病的治疗
  • 批准号:
    8913974
  • 财政年份:
    2008
  • 资助金额:
    $ 75.19万
  • 项目类别:

相似国自然基金

面向肝癌射频消融的智能建模与快速动力学分析方法研究及其临床验证
  • 批准号:
    62372469
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
IRF9调控CD8+T细胞介导微波消融联合TIGIT单抗协同增效抗肿瘤的作用机制
  • 批准号:
    82373219
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
玛纳斯河流域上游吸收性气溶胶来源及其对积雪消融的影响研究
  • 批准号:
    42307523
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
建立可诱导细胞消融系统揭示成纤维细胞在墨西哥钝口螈肢体发育及再生中的作用
  • 批准号:
    32300701
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
肿瘤源PPIA介导结直肠癌肝转移射频消融术残瘤化疗抵抗的机制研究
  • 批准号:
    82302332
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Development of an automatic real-time personalized non-invasive localization of the site of origin of the earliest ventricular activation
开发最早心室激动起源部位的自动实时个性化无创定位
  • 批准号:
    10579726
  • 财政年份:
    2023
  • 资助金额:
    $ 75.19万
  • 项目类别:
Determining the Efficacy of Corneal Cross-Linking Protocols using Brillouin Microscopy
使用布里渊显微镜确定角膜交联方案的功效
  • 批准号:
    10642876
  • 财政年份:
    2022
  • 资助金额:
    $ 75.19万
  • 项目类别:
Determining the Efficacy of Corneal Cross-Linking Protocols using Brillouin Microscopy
使用布里渊显微镜确定角膜交联方案的功效
  • 批准号:
    10443488
  • 财政年份:
    2022
  • 资助金额:
    $ 75.19万
  • 项目类别:
Magnetic Bronchoscope for Improved Pulmonary Access
用于改善肺部通路的磁力支气管镜
  • 批准号:
    10152980
  • 财政年份:
    2021
  • 资助金额:
    $ 75.19万
  • 项目类别:
Contrast-Enhanced Ultrasound for Diagnosis and Therapy of Cholangiocarcinoma
超声造影对胆管癌的诊断和治疗
  • 批准号:
    10356516
  • 财政年份:
    2021
  • 资助金额:
    $ 75.19万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了